The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Minocycline as adjunctive therapy for patients with unipolar psychotic depression: An open-label study
Abstract
Background Approximately 25% of patients admitted to a hospital as a result of depression are actually suffering from psychotic depression. Psychotic symptoms can be present in patients with either unipolar depression or bipolar depression and can be difficult to treat. It was reported the second-generation tetracycline may exert potential antidepressant effects through its robust neuroprotective activities, which include neurogenesis, antioxidation, and anti-glutamate excitotoxicity, and may direct regulation of pro-inflammatory agents.Methods This was a 6-week, open-label study to evaluate the efficacy and safety of minocycline in combination with antidepressants in adult inpatients (n=25) diagnosed with major depression with psychotic features (psychotic depression) according to DSM-IV-TR. The primary endpoint was the change from baseline in the Hamilton Depression Rating Scale (HAM-D-21) score from baseline to week 6. Secondary endpoints were changes in the Brief Psychiatric Rating Scale (BPRS) and the Clinical Global Impression (CGI) Scale scores from baseline to week 6. Spontaneously reported adverse events were recorded.Results The patients' average age was 46.9±10.2 years. Minocyline (150 mg/day) in combination with antidepressants (fulvoxamine, paroxetine, and sertraline) provided significant improvement in depression. Mean (± SD) HAM-D-21 was reduced to 6.7±1.9 at week 6 from a baseline value of 40.4±2.5. Significant improvement of psychotic symptoms (mean±SD) was indicated by the decrease in BPRS scores from baseline (63.3±8.7) to week 6 (4.6±2.4). No serious adverse events occurred.Conclusions These preliminary data suggest that minocycline in combination with antidepressants is effective and well tolerated in the treatment of unipolar psychotic depression. Further studies using larger, double-blind, parallel-group design are warranted to confirm these findings.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“and may reduce depressive symptoms (294).”
From A brain-centric model of suicidal behavior (2020) · cites this paper as [294]
In the citing paper
“Conversely, certain antibiotics, such as β-lactams and tetracyclines have potential antidepressant properties in rodents and humans [161,162].”
From Anxiety, depression, and the microbiome: A role for gut peptides (2018) · cites this paper as [162]
In the citing paper
“Preliminary findings from an open-label study confirmed minocycline antidepressant potential in individuals with unipolar psychotic depression [108].”
From Cognitive remission: a novel objective for the treatment of major depression? (2016) · cites this paper as [108]
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
Diagnostic and Statistical Manual of Mental Disorders.
Widiger, T. A. (2000) · Oxford University Press eBooks · doi:10.1037/10518-009 · Cited by 19,766
The Brief Psychiatric Rating Scale.
Overall, J. E., & Gorham, D. R. (1962) · Psychological Reports · doi:10.2466/pr0.1962.10.3.799 · Cited by 11,090
O'Connor, J. C., Lawson, M. A., André, C., Moreau, M., Lestage, J., Castanon, N., Kelley, K. W., & Dantzer, R. (2009) · Molecular Psychiatry · doi:10.1038/sj.mp.4002148 · Cited by 1,278
Evidence for an immune response in major depression: A review and hypothesis
Maes, M. (1995) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(94)00101-m · Cited by 1,003
Maes, M., Yirmyia, R., Noraberg, J., Brene, S., Hibbeln, J., Perini, G., Kubera, M., Bob, P., Lerer, B., & Maj, M. (2009) · Metabolic Brain Disease · doi:10.1007/s11011-008-9118-1 · Cited by 894
Increased Levels of Glutamate in Brains from Patients with Mood Disorders
Hashimoto, K., Sawa, A., & Iyo, M. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.03.017 · Cited by 631
Antidepressant-Induced Neurogenesis in the Hippocampus of Adult Nonhuman Primates
Perera, T. D., Coplan, J. D., Lisanby, S. H., Lipira, C. M., Arif, M., Carpio, C., Spitzer, G., Santarelli, L., Scharf, B., Hen, R., et al. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.0237-07.2007 · Cited by 476
Minocycline and Neurodegenerative Diseases
Kim, H.-S., & Suh, Y.-H. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.09.040 · Cited by 447
Flagged first, then by citations
Research works printed but not linked: 1
- Arakawa, 2012, Minocycline produced antidepressant-like effects on the learned helplessness rats with alterations in levels of monoamine in the amygdale and no changes in BDNF levels in the hippoicampus at baseline, Prog Neuropsychopharmacol Biol Psychiatry, 100, 601
Cited by
Sorted by citations
Items 101–200 of 211
Liśkiewicz, P., Pełka-Wysiecka, J., Kaczmarczyk, M., Łoniewski, I., Wroński, M., Bąba-Kubiś, A., Skonieczna‐Żydecka, K., Marlicz, W. M., Misiak, B., & Samochowiec, J. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8020164 · Cited by 44
Tremblay, M.-È. (2021) · Brain, Behavior, & Immunity - Health · doi:10.1016/j.bbih.2021.100301 · Cited by 42
Missing and Possible Link between Neuroendocrine Factors, Neuropsychiatric Disorders, and Microglia
Kato, T. A., Hayakawa, K., Monji, A., & Kanba, S. (2013) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2013.00053 · Cited by 43
Aminov, R. I. (2013) · Frontiers in Microbiology · doi:10.3389/fmicb.2013.00241 · Cited by 40
Moody microbiome: Challenges and chances
Kuo, P.-H., & Chung, Y.-C. E. (2019) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2018.09.004 · Cited by 40
Shabani, M., Ghoshehy, A., Mottaghi, A. M., Chegini, Z., Kerami, A., Shariati, A., & Moghadam, M. T. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1516010 · Cited by 48
Targeting the Inflammatory Pathway as a Therapeutic Tool for Major Depression
Noto, C. D. S., Rizzo, L. B., Mansur, R. B., McIntyre, R. S., Maes, M. H. J., & Brietzke, E. M. (2014) · NeuroImmunoModulation · doi:10.1159/000356549 · Cited by 39
Beyond the therapeutic shackles of the monoamines: new mechanisms in bipolar disorder biology
Data-Franco, J., Singh, A., Popovic, D., Ashton, M., Berk, M., Vieta, E., Figueira, M. L., & Dean, O. M. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2016.09.004 · Cited by 38
Husain, M. I., Chaudhry, I. B., Rahman, R. R., Hamirani, M. M., Qurashi, I., Khoso, A. B., Deakin, J. F. W., Husain, N., & Young, A. H. (2015) · Trials · doi:10.1186/s13063-015-0933-5 · Cited by 39
Adjunctive minocycline for major mental disorders: A systematic review
Zheng, W., Zhu, X., Zhang, Q., Cheng, G., Cai, D.-B., He, J., Ng, C. H., Ungvari, G. S., Peng, X.-J., Ning, Y., et al. (2019) · Journal of Psychopharmacology · doi:10.1177/0269881119858286 · Cited by 38
Trageser, K. J., Sebastian-Valverde, M., Naughton, S. X., & Pasinetti, G. M. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00704 · Cited by 36
Minocycline Treatment Reverses Sound Evoked EEG Abnormalities in a Mouse Model of Fragile X Syndrome
Lovelace, J. W., Ethell, I. M., Binder, D. K., & Razak, K. A. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00771 · Cited by 39
Maciel, A. L., Abelaira, H. M., de Moura, A. B., de Souza, T. G., Rosa, T., Matos, D., Tuon, T., Garbossa, L., Strassi, A. P., Fileti, M. E., et al. (2017) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2017.12.005 · Cited by 36
Minocycline does not evoke anxiolytic and antidepressant-like effects in C57BL/6 mice
Vogt, M. A., Mallien, A. S., Pfeiffer, N., Inta, I. M., Gass, P., & Inta, D. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.12.015 · Cited by 34
Drug repurposing may generate novel approaches to treating depression
Ebada, M. E. (2017) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12815 · Cited by 36
Narrative review on potential role of gut microbiota in certain substance addiction
Qin, C., Hu, J., Wan, Y., Cai, M., Wang, Z., Peng, Z., Liao, Y., Li, D., Yao, P., Liu, L., et al. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110093 · Cited by 32
Couch, Y., Xie, Q., Lundberg, L., Sharp, T., & Anthony, D. C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0130643 · Cited by 35
Anti-inflammatory effects of minocycline are mediated by retinoid signaling
Clemens, V., Regen, F., Bret, N. L., Heuser, I., & Hellmann‐Regen, J. (2018) · BMC Neuroscience · doi:10.1186/s12868-018-0460-x · Cited by 34
Microglia Sing the Prelude of Neuroinflammation-Associated Depression
Li, Q., Xie, Y., Lin, J., Li, M., Gu, Z., Xin, T., Zhang, Y., Lu, Q., Guo, Y., Xing, Y., et al. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04575-w · Cited by 30
Nettis, M. A. (2021) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2021.100335 · Cited by 32
Quantifying motivational deficits and apathy: A review of the literature
Weiser, M., & Garibaldi, G. M. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.08.018 · Cited by 31
Cohen, I. V., Makunts, T., Atayee, R. S., & Abagyan, R. A. (2017) · Scientific Reports · doi:10.1038/s41598-017-01590-x · Cited by 28
Kato, T. A., Watabe, M., & Kanba, S. (2013) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2013.00139 · Cited by 29
Modulation of high fat diet-induced microbiome changes, but not behaviour, by minocycline
Hasebe, K., Rivera, L. R., Smith, C. M., Allnutt, T. R., Crowley, T. M., Nelson, T. M., Dean, O. M., McGee, S. L., Walder, K. R., & Gray, L. J. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.09.001 · Cited by 26
Cai, D.-B., Zheng, W., Zhang, Q.-E., Ng, C. H., Ungvari, G. S., Huang, X., & Xiang, Y. (2020) · Psychiatric Quarterly · doi:10.1007/s11126-019-09707-3 · Cited by 26
Husain, M. I., Chaudhry, I. B., Hamirani, M. M., Minhas, F., Kazmi, A., Hodsoll, J. P., Haddad, P. M., Deakin, J. F. W., Husain, N., & Young, A. H. (2016) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s115002 · Cited by 25
Visceral Pain and Psychiatric Disorders
Felice, V. D., Moloney, R. D., Cryan, J. F., Dinan, T. G., & O’Mahony, S. M. (2015) · Modern trends in psychiatry · doi:10.1159/000435936 · Cited by 27
Matrix metalloproteinase‐9: A magic drug target in neuropsychiatry?
Kaczmarek, K. T., Protokowicz, K., & Kaczmarek, L. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15976 · Cited by 23
Mello, B. S. F., Filho, A. J. M. C., Custódio, C. S., Rodrigues, P. D. A., Carletti, J. V., Vasconcelos, S. M. M., de Sousa, F. C. F., Sanders, L. L. O., & Macêdo, D. S. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.05.083 · Cited by 22
Smiley, C. E., & Wood, S. K. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108212 · Cited by 24
Wang, B., Chen, T., Li, X., Wang, J., Jia, Y., Li, G., Ren, H., Wu, F., Wu, M., & Chen, Y. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.04.053 · Cited by 21
Hamidkhaniha, S., Bashiri, H., Omidi, A., Hosseini‐Chegeni, A., Tavangar, S. M., Sabouri, S., Montazeri, H., & Sahebgharani, M. (2019) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13090 · Cited by 20
Chan, S. Y., Capitão, L. P., Probert, F., Klinge, C., Höckner, S., Harmer, C. J., Cowen, P. J., Anthony, D. C., & Burnet, P. W. J. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-0818-6 · Cited by 19
Namiot, E. D., Smirnovová, D., Sokolov, A. V., Chubarev, V. N., Tarasov, V. V., & Schiöth, H. B. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-03031-6 · Cited by 23
Branchi, I., Viglione, A., Vai, B., Cirulli, F., Benedetti, F., & Poggini, S. (2023) · Neuroscience Applied · doi:10.1016/j.nsa.2023.103923 · Cited by 18
Motafeghi, F. S., Bagheri, A., Seyedabadi, M., Shaki, F., & Shokrzadeh, M. (2022) · Neurotoxicity Research · doi:10.1007/s12640-022-00603-6 · Cited by 17
Michaelis, L., Berg, L., & Maier, L. (2023) · Biological Psychiatry · doi:10.1016/j.biopsych.2023.06.004 · Cited by 20
Inhibition of brain retinoic acid catabolism: a mechanism for minocycline's pleiotropic actions?
Regen, F., Bret, N. L., Hildebrand, M., Herzog, I., Heuser, I., & Hellmann‐Regen, J. (2015) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2015.1036116 · Cited by 20
Filho, A. J. M. C., Mottin, M., Soares, M. V.-R., Jucá, P. M., Andrade, C. H., & Macêdo, D. S. (2021) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000585 · Cited by 17
Nutraceuticals and Physical Activity as Antidepressants: The Central Role of the Gut Microbiota
Zeppa, S. D., Ferrini, F., Agostini, D., Amatori, S., Barbieri, E., Piccoli, G., Sestili, P., & Stocchi, V. (2022) · Antioxidants · doi:10.3390/antiox11020236 · Cited by 20
Minocycline, a microglial inhibitor, reduces ‘honey trap’ risk in human economic exchange
Watabe, M., Kato, T. A., Tsuboi, S., Ishikawa, K., Hashiya, K., Monji, A., Utsumi, H., & Kanba, S. (2013) · Scientific Reports · doi:10.1038/srep01685 · Cited by 18
Biomarkers of stress resilience: A review
Paribello, P., Branchi, I., Viglione, A., Mancini, G. F., Morena, M., Campolongo, P., & Manchia, M. (2024) · Neuroscience Applied · doi:10.1016/j.nsa.2024.104052 · Cited by 17
Queiroz, A. I. G., Filho, A. J. M. C., Araújo, T. D. S., Lima, C. N. D. C., Machado, M. D. J. S., Carvalho, A. F., Vasconcelos, S. M. M., de Lucena, D. F., Quevedo, J., & Macêdo, D. S. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.07.053 · Cited by 16
Antipsychotic-like effect of minocycline in a rat model.
Dokuyucu, R., Kokaçya, M. H., İnanır, S., Çöpoğlu, Ü. S., & Erbaş, O. (2014) · PubMed Central · Cited by 14
Takahashi, K., Tsuji, M., Nakagawasai, O., Katsuyama, S., Miyagawa, K., Kurokawa, K., Mochida-Saito, A., Takeda, H., & Tadano, T. (2024) · Neurochemistry International · doi:10.1016/j.neuint.2024.105723 · Cited by 13
Metabolic syndrome-associated cognitive decline in mice: Role of minocycline
Banerjee, S., Mukherjee, A., Mehta, B. K., & Sen, K. K. (2018) · Indian Journal of Pharmacology · doi:10.4103/ijp.ijp_110_18 · Cited by 13
Lin, T., Du, J., Liu, L., Wu, Z., Kong, X., Liu, Y., & Cai, Y. (2020) · BioMed Research International · doi:10.1155/2020/7348745 · Cited by 13
Wang, N., Zhu, S., Chen, S., Zou, J., Zeng, P., & Tan, S. (2025) · Reviews in the Neurosciences · doi:10.1515/revneuro-2024-0147 · Cited by 12
Li, X., Peng, Z., Jiang, L., Zhang, P., Yang, P., Yuan, Z., & Cheng, J. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1124845 · Cited by 11
Mardini, V., Rohde, L. A., Ceresér, K. M. M., Gubert, C., da Silva, E. G., Xavier, F., Parcianello, R. R., Röhsig, L. M., Pechansky, F., Pianca, T. G., et al. (2016) · Trends in Psychiatry and Psychotherapy · doi:10.1590/2237-6089-2015-0081 · Cited by 12
Fond, G. B., Chevalier, G., Eberl, G., & Leboyer, M. (2015) · La Presse Médicale · doi:10.1016/j.lpm.2015.10.016 · Cited by 14
Halaris, A. E., & Leonard, B. E. (2019) · Neurology Psychiatry and Brain Research · doi:10.1016/j.npbr.2019.05.005 · Cited by 11
Gut-Microbiome Implications in Opioid Use Disorder and Related Behaviors
Herlihy, B., & Roy, S. (2022) · Advances in Drug and Alcohol Research · doi:10.3389/adar.2022.10311 · Cited by 10
Probiotics: A potential immunotherapeutic approach for the treatment of schizophrenia
Patil, A., Grover, S., Kaur, A., & Garg, G. (2019) · Journal of Pharmacy And Bioallied Sciences · doi:10.4103/jpbs.jpbs_47_19 · Cited by 10
Guidelines for the management of psychosis in the context of mood disorders
Bassett, D. L., Boyce, P. M., Lyndon, B., Mulder, R., Parker, G. B., Porter, R., Singh, A., Bell, E., Hamilton, A., Morris, G., et al. (2022) · Schizophrenia Research · doi:10.1016/j.schres.2022.01.047 · Cited by 10
Takahashi, K., Nakagawasai, O., Kurokawa, K., Miyagawa, K., Mochida-Saito, A., Takeda, H., & Tsuji, M. (2025) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-025-10232-3 · Cited by 9
Gonda, X., Serafini, G., & Döme, P. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13071078 · Cited by 9
Molina-Hernández, M., Téllez-Alcántara, N. P., Olivera-Lopez, J. I., & Jaramillo, M. T. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3251-1 · Cited by 9
Impact of the gut microbiota on the neuroendocrine and behavioural responses to stress in rodents
Rabot, S., Jaglin, M., Daugé, V., & Naudon, L. (2015) · OCL · doi:10.1051/ocl/2015036 · Cited by 9
Depression in the Context of Medical Disorders: New Pharmacological Pathways Revisited
Lang, U. E., & Walter, M. (2017) · Neurosignals · doi:10.1159/000482001 · Cited by 9
Supporting microglial niches for therapeutic benefit in psychiatric disorders
Churchward, M. A., Michaud, E., & Todd, K. G. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.109648 · Cited by 9
An Update on the Relationship Between the Gut Microbiome and Obsessive-Compulsive Disorder
Turna, J., Patterson, B. A., & Ameringen, M. V. (2017) · Psychiatric Annals · doi:10.3928/00485713-20171013-01 · Cited by 8
Lisiecka, D. M., John Suckling, A., Barnes, T. R. E., Chaudhry, I. B., Dazzan, P., Husain, N., Jones, P. B., Joyce, E. M., Lawrie, S. M., Upthegrove, R., et al. (2015) · Trials · doi:10.1186/s13063-015-0580-x · Cited by 8
GPR120 internalization: a key mechanism for EPA in antidepressant action
Yu, Q., Li, H., Chen, M., Pan, Y., Zhou, L., An, L., Zhao, J., Bai, S., Liang, Q., Zhang, R., et al. (2025) · Food & Function · doi:10.1039/d5fo00252d · Cited by 8
The clinical outcomes of gut-brain axis (GBA) microbiota influence on psychiatric disorders
Navidinia, M., Goudarzi, M., & Seyfi, E. (2023) · Iranian Journal of Microbiology · doi:10.18502/ijm.v15i1.11912 · Cited by 7
The Gut Microbiome Affects Human Mood and Behavior
Villa, T. G., & Sánchez-Pérez, A. (2021) · Springer eBooks · doi:10.1007/978-3-030-77595-7_22 · Cited by 6
Depressive symptoms and inflammatory markers following acute myocardial infarction: A scoping review
Mensour, E., Liblik, K., Mantella, L. E., & Johri, A. M. (2022) · Health Sciences Review · doi:10.1016/j.hsr.2022.100020 · Cited by 5
Herrero-Zazo, M., Brauer, R., Gaughran, F., Howard, L. M., Taylor, D. M., & Barlow, D. J. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881117743483 · Cited by 6
Depression and Anxiety Disorders
Karamustafalıoğlu, O., & Yumrukçal, H. (2025) · Wiley eBooks · doi:10.1002/9781119870203.mpg003.pub2 · Cited by 8
Sleep, Cognitive and Mood Symptoms in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Wallis, A., Jackson, M. L., Ball, M., Lewis, D. P., & Bruck, D. (2017) · Wiley eBooks · doi:10.1002/9781118993811.ch31 · Cited by 7
Tan, L., Zhao, W., Wang, H. Y., Huang, X., Lin, Y., Yin, L., Liu, X., Wang, J., Wu, N., & Wang, H. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03167-x · Cited by 8
Grizzell, J. A., Clarity, T. T., Rodriguez, R. M., Marshall, Z. Q., & Cooper, M. A. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.08.043 · Cited by 5
Antibiotic exposure is associated with decreased risk of psychiatric disorders
Kerman, I. A., Glover, M. E., Lin, Y., West, J. L., Hanlon, A. L., Kablinger, A. S., & Clinton, S. M. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1290052 · Cited by 7
Kumar, P., Harmer, C. J., & Dourish, C. T. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-386945-6.00012-3 · Cited by 6
Vaccination and Immunotherapy for Major Depression
Evrensel, A., Ünsalver, B. Ö., Ceylan, M. E., & Tarhan, N. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-981-33-6044-0_25 · Cited by 5
Szablewski, L. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819265-8.00065-6 · Cited by 5
Zhou, K., Xie, Y., Xie, X., Li, H., Liang, T., Li, J., & Liu, J. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.119437 · Cited by 6
Potential Anti-Depressive Treatment Maneuvers from Bench to Bedside
Cai, M., Wang, H., & Zhang, X. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-32-9271-0_15 · Cited by 4
Role of Gastrointestinal Tract (GUT) Health in Reducing Non-communicable Disease Risk
Tripti, T., & Ghosh, J. (2025) · Journal of Comprehensive Health · doi:10.25259/jch_29_2024 · Cited by 3
Efficacy of Anti-Inflammatory Treatment in Depression
Köhler‐Forsberg, O., & Benros, M. E. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811073-7.00030-1 · Cited by 3
Advances in the Treatment of Psychotic Depression
Thompson, A. R., Malhotra, A., & Rothschild, A. J. (2019) · Current Treatment Options in Psychiatry · doi:10.1007/s40501-019-0167-3 · Cited by 3
Major Depression: An Immune-Inflammatory Disorder
Noto, C. D. S., Rizzo, L. B., Mansur, R. B., Brietzke, E. M., & Maes, M. H. J. (2015) · Current topics in neurotoxicity · doi:10.1007/978-3-319-13602-8_8 · Cited by 3
Immunomodulation of Resistant Depression
Bennabi, D., & Haffen, É. (2021) · Springer eBooks · doi:10.1007/978-3-030-71229-7_23 · Cited by 2
211. Inflammation and treatment resistance in major depression: A perfect storm
Miller, A. H. (2011) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2011.07.214 · Cited by 3
Modulators of Glutamatergic Signaling as Potential Treatments for Autism Spectrum Disorders
Sogos, C., & Fioriello, F. (2022) · Springer eBooks · doi:10.1007/978-3-030-87480-3_20 · Cited by 2
Gómez-Chavarı́n, M., & Morales-Gómez, M. R. (2017) · Archivos de Neurociencias · doi:10.31157/an.v22i2.153 · Cited by 2
Kotova, M. M., Kolesnikova, T. O., Amikishiev, S. V., Riga, V. D., de Abreu, M. S., Евгеньевич, М. П., & Kalueff, A. V. (2026) · Brain Sciences · doi:10.3390/brainsci16080815 · Cited by 1
Improving the treatment for depressive symptoms and major depression with anti-inflammatory drugs
Zunszain, P. A. (2015) · Evidence-Based Mental Health · doi:10.1136/eb-2015-102063 · Cited by 1
Yirmiya, D., Rimmerman, N., & Reshef, R. (2015) · Cited by 1
Kato, T. A., Ohgidani, M., Sagata, N., & Kanba, S. (2016) · Advances in Neuroimmune Biology · doi:10.3233/nib-160109 · Cited by 2
[Anatomy of the external saphenous vein].
Payen, B. (1985) · PubMed · Cited by 4
Parreira, G. M., de Oliveira, A. C. P., Guarnieri, L. D. O., & Vieira, R. P. (2024) · Frontiers in clinical drug research. CNS and neurological disorders · doi:10.2174/9789815179842124120007 · Cited by 1
Präklinische Einblicke in das Zusammenspiel von Mikrobiota und Verhalten
Schmidtner, A. K., & Neumann, I. D. (2020) · Nervenheilkunde · doi:10.1055/a-1036-4206 · Cited by 1
Marcatili, M., Borgonovo, R., Cimminiello, N., Cornaggia, R. D., Casati, G., Pellicioli, C., Maggioni, L., Motta, F. L., Chiara, R., Ledda, L., et al. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12091524 · Cited by 1
Biological mechanisms of environmental stressors in psychiatry : the role of the immune system
Guloksuz, I. S. (2015) · Research Publications (Maastricht University) · doi:10.26481/dis.20151202ig · Cited by 1
Role of Interferon-Gamma and Leucine-Rich Repeat Kinase 2 in Stress-Related Pathology
Litteljohn, D. (2016) · Carleton University's Institutional Repository (MacOdrum Library, Carleton University) · doi:10.22215/etd/2016-11660
Depression and Anxiety Disorders
(2021) · Wiley eBooks · doi:10.1002/9781119870203.mpg003 · Cited by 1
Chen, L.-Q., Lv, X., Guo, Q.-H., Lv, S.-S., Lv, N., Yu, J., Xu, W., & Zhang, Y.-Q. (2022) · bioRxiv · doi:10.1101/2022.04.16.488241 · Cited by 2
Myint, A.-M., & Schwarz, M. (2015) · Current topics in neurotoxicity · doi:10.1007/978-3-319-13602-8_10
Quantitative Evaluation of Microglial Activation and Vascularization in Suicide
Schnieder, T. P. (2014) · CUNY Academic Works (City University of New York)
Metadata
- Authors
- Miyaoka, T., Wake, R., Furuya, M., Liaury, K., Ieda, M., Kawakami, K., Tsuchie, K., Taki, M., Ishihara, K., Araki, T., & Horiguchi, J.
- Affiliations
- Shimane University (JP)
- Corresponding author
- Miyaoka, Tsuyoshi
- Venue
- Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Publisher
- Elsevier BV
- Published
- 2012-06
- Volume
- 37
- Issue
- 2
- Pages
- 222-226
- ISSN
- 0278-5846 (ISSN-L)
- OpenAlex
- W2002519510
- Cited by
- 212
- References
- 42
- Citations by year
- 2026: 3 · 2025: 8 · 2024: 10 · 2023: 6 · 2022: 16 · 2021: 15 · 2020: 17 · 2019: 16 · 2018: 13 · 2017: 28 · 2016: 23 · 2015: 26 · 2014: 11 · 2013: 13 · 2012: 5
- FWCI
- 12.94
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Progress in Neuro-Psychopharmacology and Biological Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Ministry of Education, Culture, Sports, Science and Technology
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- minocycline, psychotic depression, major depressive disorder, adjunctive therapy, antidepressants, paroxetine, sertraline, neuroprotection, neurogenesis, anti-inflammatory activity, antidepressant efficacy, drug safety
- MeSH terms
- Adult, Antidepressive Agents, Depressive Disorder, Drug Therapy, Combination, Female, Humans, Male, Middle Aged, Minocycline, Psychotic Disorders, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review